Alirocumab

Common brands: Praluent, Aspirin 325, Aspirin 81, Ecotrin, Low Dose Aspirin

Top reporter: Regeneron Pharmaceuticals, Inc.

PCSK9 Inhibitor [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Platelet Aggregation Inhibitor [EPC]Dietary Cholesterol Absorption Inhibitor [EPC]Provitamin D2 Compound [EPC]
24,642
Total Reports
6,407
Serious Reports
498
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (2.02%)

Patient Demographics

Male
8,725
Female
12,675

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Alirocumab.

# Reaction Reports % of Total
1 MYALGIA 1,667
6.9%
2 PRODUCT DOSE OMISSION 1,364
5.6%
3 INJECTION SITE PAIN 1,286
5.3%
4 MUSCLE SPASMS 1,168
4.8%
5 ARTHRALGIA 1,062
4.4%
6 FATIGUE 1,023
4.2%
7 PAIN 952
3.9%
8 PAIN IN EXTREMITY 939
3.9%
9 PRODUCT DOSE OMISSION ISSUE 911
3.8%
10 INJECTION SITE BRUISING 848
3.5%
11 HEADACHE 805
3.3%
12 INFLUENZA LIKE ILLNESS 803
3.3%
13 DIARRHOEA 801
3.3%
14 DEVICE ISSUE 788
3.3%
15 COUGH 708
2.9%
16 INJECTION SITE ERYTHEMA 702
2.9%
17 DYSPNOEA 697
2.9%
18 PRURITUS 696
2.9%
19 INJECTION SITE HAEMORRHAGE 685
2.8%
20 RASH 673
2.8%
21 NAUSEA 658
2.7%
22 DIZZINESS 634
2.6%
23 MALAISE 616
2.5%
24 NASOPHARYNGITIS 584
2.4%
25 DRUG INEFFECTIVE 579
2.4%
26 RHINORRHOEA 533
2.2%
27 PRODUCT DELIVERY MECHANISM ISSUE 526
2.2%
28 BACK PAIN 522
2.2%
29 ASTHENIA 491
2.0%
30 CONDITION AGGRAVATED 479
2.0%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.